Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Nana Koram, PhD, MPH
Pharmacoepidemiologist
Pfizer Inc.
Poster(s):
(005) Challenges, Lessons Learned and Implications for Improvement in Employing Drug Utilization Studies to Evaluate the Effectiveness of Additional Risk Minimization Measures (aRMMs)
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
